Tag: Patients

A differentiated effector T cell repertoire defines a functionally high-risk group of smoldering myeloma patients

A differentiated effector T cell repertoire defines a functionally high-risk group of smoldering myeloma patients

A differentiated effector T cell repertoire defines a functionally high-risk group of smoldering myeloma patients ...

READ MORE
Tumor-localized CD40 agonism with MP0317, a FAP x CD40 DARPin, reprograms the tumor microenvironment in patients with advanced solid tumors: an open-label, nonrandomized, dose-escalation phase 1 study

Tumor-localized CD40 agonism with MP0317, a FAP x CD40 DARPin, reprograms the tumor microenvironment in patients with advanced solid tumors: an open-label, nonrandomized, dose-escalation phase 1 study

Study design, patient eligibility and treatment This was a phase 1, first-in-human, open-label, nonrandomized, dose-escalation ...

READ MORE
Tumor DNA methylation subtypes predict immunotherapy outcomes in pleural mesothelioma patients in the NIBIT-EPI-MESO study

Tumor DNA methylation subtypes predict immunotherapy outcomes in pleural mesothelioma patients in the NIBIT-EPI-MESO study

Calabrò, L. et al. Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, ...

READ MORE
TH5487 specifically targets NLRP3 in FCAS patients resistant to MCC950

TH5487 specifically targets NLRP3 in FCAS patients resistant to MCC950

Further information can be found in Supplemental Methods Sex as a biological variable Our study ...

READ MORE
Study Shows This Diet Raises Cardiac Event Risk By 82% In Heart Disease Patients

Study Shows This Diet Raises Cardiac Event Risk By 82% In Heart Disease Patients

And how to eat an anti-inflammatory diet instead. ...

READ MORE
Immune reconstitution in patients with myelofibrosis conditioned with a non-myeloablative regimen prior to allogeneic stem cell transplantation

Immune reconstitution in patients with myelofibrosis conditioned with a non-myeloablative regimen prior to allogeneic stem cell transplantation

Luther M, Henes FO, Zabelina T, Massoud R, Janson D, Wolschke C, et al. Spleen ...

READ MORE
Haploidentical transplantation with post-transplant cyclophosphamide is not inferior to 9/10-MUD transplantation with ATG in patients with myeloid malignancies

Haploidentical transplantation with post-transplant cyclophosphamide is not inferior to 9/10-MUD transplantation with ATG in patients with myeloid malignancies

Horan JT, Logan BR, Agovi-Johnson MA, Lazarus HM, Bacigalupo AA, Ballen KK, et al. Reducing ...

READ MORE
Second alternative-donor haploidentical stem cell transplantation enhances survival in patients with myeloid malignancies complicated by posttransplant human leukocyte antigen loss relapse

Second alternative-donor haploidentical stem cell transplantation enhances survival in patients with myeloid malignancies complicated by posttransplant human leukocyte antigen loss relapse

Passweg JR, Baldomero H, Bader P, Bonini C, Duarte RF, Dufour C, et al. Use ...

READ MORE
Mutational landscape changes of AML in patients relapsing after allogeneic hematopoietic cell transplantation

Mutational landscape changes of AML in patients relapsing after allogeneic hematopoietic cell transplantation

Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, et al. International ...

READ MORE
This 5-day diet helped Crohn’s patients feel better fast

This 5-day diet helped Crohn’s patients feel better fast

“What should I eat?” is one of the most common questions people with inflammatory bowel ...

READ MORE